Lista de obras -

All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells

artículo científico publicado en 2004

BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation ⬇️

artículo científico publicado el 1 de octubre de 1997

Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia

artículo científico publicado en 2001

Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas

scientific article published on 01 October 1999

Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes.

artículo científico publicado en 2015

Consolidation treatment for primary central nervous system lymphoma: which modality for whom?

Scientific article published on 26 November 2021

Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia

artículo científico publicado en 2003

Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.

artículo científico publicado en 2007

Early death in patients diagnosed with non-Hodgkin’s lymphoma ⬇️

artículo científico publicado el 17 de noviembre de 2012

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

Scientific article published on 3 February 2022

First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis

artículo científico publicado en 2015

Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel

artículo científico publicado en 2018

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.

artículo científico publicado en 2015

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado en 2015

Increased thromboembolic events after lung transplantation

artículo científico publicado en 2006

Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group

artículo científico publicado en 2012

Is bone marrow biopsy obligatory in all patients with non-Hodgkin's lymphoma?

artículo científico publicado en 2007

Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature

artículo científico publicado en 2010

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

artículo científico publicado en 2019

Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience

scientific article published on 12 March 2019

Mortalin peptides exert antitumor activities and act as adjuvants to antibody-mediated complement-dependent cytotoxicity

scientific article published on 16 July 2020

Non-Hodgkin's lymphoma in patients 80 years of age or older

artículo científico publicado en 2006

Non-Hodgkin's lymphomas of the colon

artículo científico publicado en 2006

Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma

scientific article published on 01 May 1994

Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study ⬇️

artículo científico publicado el 26 de mayo de 2011

Primary CNS Lymphoma in the Elderly: The Challenge

artículo científico publicado en 2019

Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma

artículo científico publicado en 2009

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Scientific article published on 1 March 2022

Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma

artículo científico publicado en 2003

Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor

artículo científico publicado en 2015

Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients

artículo científico publicado en 1999

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2

artículo científico publicado en 2018

The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma

artículo científico publicado en 2008

Updated Efficacy and Safety from the Phase 3 Resonate-2 Study: Ibrutinib As First-Line Treatment Option in Patients 65 Years and Older with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia

Scientific article published on 2 Dec 2016

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions

artículo científico publicado en 2007

Lista de obras de

All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells

BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation ⬇️

Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia

Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas

Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes.

Consolidation treatment for primary central nervous system lymphoma: which modality for whom?

Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia

Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.

Early death in patients diagnosed with non-Hodgkin’s lymphoma ⬇️

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis

Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia ⬇️

Increased thromboembolic events after lung transplantation

Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group

Is bone marrow biopsy obligatory in all patients with non-Hodgkin's lymphoma?

Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience

Mortalin peptides exert antitumor activities and act as adjuvants to antibody-mediated complement-dependent cytotoxicity

Non-Hodgkin's lymphoma in patients 80 years of age or older

Non-Hodgkin's lymphomas of the colon

Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma

Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study ⬇️

Primary CNS Lymphoma in the Elderly: The Challenge

Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma

Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor

Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2

The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma

Updated Efficacy and Safety from the Phase 3 Resonate-2 Study: Ibrutinib As First-Line Treatment Option in Patients 65 Years and Older with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions